Target Name: AKAP2
NCBI ID: G11217
Review Report on AKAP2 Target / Biomarker Content of Review Report on AKAP2 Target / Biomarker
AKAP2
Other Name(s): AKAP2_HUMAN | PALM2 | PRKA2 | PALM2-AKAP2 protein | Protein kinase A2 | PALM2-AKAP2 | A kinase (PRKA) anchor protein 2, transcript variant 1 | OTTHUMP00000063892 | A-kinase anchor protein 2 | Protein kinase A anchoring protein 2 | AKAP-2 | KIAA0920 | FLJ53197 | AKAP2 variant 1 | A kinase (PRKA) anchor protein 2 | Protein kinase A-anchoring protein 2 | A-kinase anchor protein 2 (isoform 1) | AKAPKL | AKAP-KL

Understanding The Potential Applications of AKAP2

AKAP2 (AKAP2-HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and kidneys. It is a member of the AKAP2 family of proteins, which are involved in various cellular processes, including intracellular signaling and stress response. While AKAP2 has been identified as a potential drug target and biomarker for various diseases, more research is needed to fully understand its role and potential applications in medicine.

The AKAP2 gene was identified in the late 1990s by researchers at the University of California, San Diego. The gene is located on chromosome 6 and encodes a protein that is 21 kDa in size. AKAP2 is highly conserved, with similar sequences found in various species, including humans, mice, and yeast.

AKAP2 is involved in various cellular processes that are important for normal cellular function and development. One of its main functions is to regulate the distribution of intracellular signaling molecules, such as neurotransmitters and hormones. It does this by interacting with various protein partners, including the neurotransmitter transporter SNAP25.

In addition to its role in intracellular signaling, AKAP2 is also involved in the regulation of cellular stress responses. It has been shown to play a key role in the stress response pathway, which is activated in response to various stressors, including starvation, exercise, and tissue damage.

The potential applications of AKAP2 as a drug target and biomarker are vast. In addition to its involvement in intracellular signaling and stress response, AKAP2 has also been shown to be involved in various other cellular processes that are important for normal cellular function.

For example, studies have shown that AKAP2 is involved in the regulation of cell migration, which is important for the development and maintenance of tissues and organs. In addition, AKAP2 has been shown to be involved in the regulation of cell adhesion, which is important for the formation of tissues and organs and the development of various diseases, including cancer.

In addition to its role in cellular signaling and stress response, AKAP2 has also been shown to play a key role in the regulation of inflammation. It has been shown to interact with various immune cells, including T cells and macrophages, and to be involved in the regulation of their activity.

The potential applications of AKAP2 as a drug target and biomarker are vast. In addition to its involvement in intracellular signaling and stress response, AKAP2 has also been shown to be involved in various other cellular processes that are important for normal cellular function.

In conclusion, AKAP2 is a protein that is expressed in various tissues of the human body and is involved in various cellular processes that are important for normal cellular function. While more research is needed to fully understand its role and potential applications in medicine, its potential as a drug target and biomarker for various diseases is significant.

Protein Name: A Kinase (PRKA) Anchor Protein 2, Transcript Variant 1

The "AKAP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AKAP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

AKAP3 | AKAP4 | AKAP5 | AKAP6 | AKAP7 | AKAP8 | AKAP8L | AKAP9 | AKIP1 | AKIRIN1 | AKIRIN2 | AKNA | AKNAD1 | AKR1A1 | AKR1B1 | AKR1B10 | AKR1B10P1 | AKR1B15 | AKR1C1 | AKR1C2 | AKR1C3 | AKR1C4 | AKR1C6P | AKR1C8 | AKR1D1 | AKR1E2 | AKR7A2 | AKR7A2P1 | AKR7A3 | AKR7L | AKT1 | AKT1S1 | AKT2 | AKT3 | AKTIP | ALAD | ALAS1 | ALAS2 | ALB | ALCAM | Alcohol Dehydrogenase | Alcohol dehydrogenase Class 1 | Aldehyde Dehydrogenase | ALDH16A1 | ALDH18A1 | ALDH1A1 | ALDH1A2 | ALDH1A3 | ALDH1A3-AS1 | ALDH1B1 | ALDH1L1 | ALDH1L1-AS1 | ALDH1L2 | ALDH2 | ALDH3A1 | ALDH3A2 | ALDH3B1 | ALDH3B2 | ALDH4A1 | ALDH5A1 | ALDH6A1 | ALDH7A1 | ALDH8A1 | ALDH9A1 | Aldo-Keto Reductase Family 1 | ALDOA | ALDOAP2 | ALDOB | ALDOC | ALG1 | ALG10 | ALG10B | ALG11 | ALG12 | ALG13 | ALG14 | ALG1L10P | ALG1L13P | ALG1L1P | ALG1L2 | ALG1L5P | ALG1L7P | ALG1L8P | ALG2 | ALG3 | ALG5 | ALG6 | ALG8 | ALG9 | ALK | ALKAL1 | ALKAL2 | Alkaline Phosphatase (ALP) | ALKBH1 | ALKBH2 | ALKBH3 | ALKBH4 | ALKBH5 | ALKBH6 | ALKBH7